A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients

PURPOSE: Combination therapy with aprepitant, serotonin receptor antagonist, and steroids improves the complete response rate of both acute and delayed chemotherapy-induced nausea and vomiting (CINV). However, it is not known whether ramosetron is suitable for administration in combination with apre...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jang, Geundoo, Song, Hun Ho, Park, Keon Uk, Kim, Hyeong Su, Choi, Dae Ro, Kwon, Jung Hye, Kim, Ho Young, Han, Boram, Kim, Jung Han, Jung, Joo Young, Kim, Hyo Jung, Zang, Dae Young
Формат: Artigo
Язык:Inglês
Опубликовано: Korean Cancer Association 2013
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804728/
https://ncbi.nlm.nih.gov/pubmed/24155675
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2013.45.3.172
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы